MDPI and ACS Style
Bistué-Rovira, À.; Rico, L.G.; Bardina, J.; Juncà , J.; Granada, I.; Bradford, J.A.; Ward, M.D.; Salvia, R.; Solé, F.; Petriz, J.
Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance. Int. J. Mol. Sci. 2024, 25, 1994.
https://doi.org/10.3390/ijms25041994
AMA Style
Bistué-Rovira À, Rico LG, Bardina J, Juncà J, Granada I, Bradford JA, Ward MD, Salvia R, Solé F, Petriz J.
Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance. International Journal of Molecular Sciences. 2024; 25(4):1994.
https://doi.org/10.3390/ijms25041994
Chicago/Turabian Style
Bistué-Rovira, Àngel, Laura G. Rico, Jorge Bardina, Jordi Juncà , Isabel Granada, Jolene A. Bradford, Michael D. Ward, Roser Salvia, Francesc Solé, and Jordi Petriz.
2024. "Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance" International Journal of Molecular Sciences 25, no. 4: 1994.
https://doi.org/10.3390/ijms25041994